Cargando…

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond

We highlight the significant progress in developing DNA vaccines during the SARS-CoV-2 pandemic. Specifically, we provide a comprehensive review of the DNA vaccines that have progressed to Phase 2 testing or beyond, including those that have received authorization for use. DNA vaccines have signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maslow, Joel N., Kwon, Ijoo, Kudchodkar, Sagar B., Kane, Deborah, Tadesse, Amha, Lee, Hyojin, Park, Young K., Muthumani, Kar, Roberts, Christine C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302025/ https://www.ncbi.nlm.nih.gov/pubmed/37376404 http://dx.doi.org/10.3390/vaccines11061016

Ejemplares similares

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost
por: Kim, Woo Joo, et al.
Publicado: (2023)

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
por: Kim, Woo Joo, et al.
Publicado: (2023)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

Novel suction-based in vivo cutaneous DNA transfection platform
por: Lallow, Emran O., et al.
Publicado: (2021)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics
por: Dwibedi, Bhagirathi
Publicado: (2020)

SARS-CoV-2 and displaced persons in Afghanistan: A blind spot in epidemic preparedness
por: Flower, Benjamin CR, et al.
Publicado: (2020)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
por: Jiang, Jingjing, et al.
Publicado: (2021)

Preclinical safety assessment of the suction-assisted intradermal injection of the SARS-CoV-2 DNA vaccine candidate pGO-1002 in white rabbit
por: Oh, Seunghee, et al.
Publicado: (2023)

SARS-CoV-2 Epidemics in Retirement and Nursing Homes in Italy: A New Preparedness Assessment Model after the First Epidemic Wave
por: Gugliotta, Carmelo, et al.
Publicado: (2021)

Importance of diagnostics in epidemic and pandemic preparedness
por: Kelly-Cirino, Cassandra D, et al.
Publicado: (2019)

India - National disaster and epidemic preparedness
por: Menon, V.C.
Publicado: (2016)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Epidemic preparedness and management: A guide on Lassa fever outbreak preparedness plan
por: Fatiregun, Akinola Ayoola, et al.
Publicado: (2017)

Assessing global preparedness for the next pandemic: development and application of an Epidemic Preparedness Index
por: Oppenheim, Ben, et al.
Publicado: (2019)

Epidemic preparedness: Prenatal Zika virus screening during the next epidemic
por: Qiao, Luxi, et al.
Publicado: (2021)

Enhancing preparedness for tackling new epidemic threats
por: Zumla, Alimuddin, et al.
Publicado: (2017)

GETTING TO BETTER PANDEMIC AND EPIDEMIC PREPAREDNESS AND RESPONSE
por: Abdelmalik, Philip
Publicado: (2023)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

SARS-CoV-2 and Zoonotic Preparedness: Unknown Knowns?
por: Irving, Aaron Trent, et al.
Publicado: (2021)

Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018)

Towards pandemic preparedness beyond COVID-19
por: Naguib, Mahmoud M, et al.
Publicado: (2020)

Are we prepared? Lessons from Covid-19 and OMAG position paper on epidemic preparedness
por: Raina, Sunil Kumar, et al.
Publicado: (2020)

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
por: Modjarrad, Kayvon, et al.
Publicado: (2019)

Hospital Preparedness and SARS
por: Loutfy, Mona R., et al.
Publicado: (2004)

Epidemic preparedness in urban settings: new challenges and opportunities
por: Lee, Vernon J, et al.
Publicado: (2020)

CEPI: Driving Progress Toward Epidemic Preparedness and Response
por: Gouglas, Dimitrios, et al.
Publicado: (2019)

Financing of international collective action for epidemic and pandemic preparedness
por: Yamey, Gavin, et al.
Publicado: (2017)

Global challenges in preparedness and response to epidemic infectious diseases
por: Olliaro, Piero, et al.
Publicado: (2022)

Epidemic preparedness for COVID-19: A major challenge!
por: Gogia, Priya, et al.
Publicado: (2020)

Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach
por: Zeyaullah, Md., et al.
Publicado: (2022)

Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
por: Matheeussen, Veerle, et al.
Publicado: (2020)

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing
por: Mahalingam, Sundarasamy, et al.
Publicado: (2021)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dp7k31o3ug6p15fnue4sb77crc